| Literature DB >> 28815024 |
Meike Hohwieler1, Lukas Perkhofer1, Stefan Liebau2, Thomas Seufferlein1, Martin Müller1, Anett Illing1, Alexander Kleger1.
Abstract
Cystic fibrosis (CF) is one of the most frequently occurring inherited human diseases caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) which lead to ample defects in anion transport and epithelial fluid secretion. Existing models lack both access to early stages of CF development and a coeval focus on the gastrointestinal CF phenotypes, which become increasingly important due increased life span of the affected individuals. Here, we provide a comprehensive overview of gastrointestinal facets of CF and the opportunity to model these in various systems in an attempt to understand and treat CF. A particular focus is given on forward-leading organoid cultures, which may circumvent current limitations of existing models and thereby provide a platform for drug testing and understanding of disease pathophysiology in gastrointestinal organs.Entities:
Keywords: Pancreas development; cystic fibrosis; induced pluripotent stem cells; organoids; stem cells
Year: 2016 PMID: 28815024 PMCID: PMC5548342 DOI: 10.1177/2050640616670565
Source DB: PubMed Journal: United European Gastroenterol J ISSN: 2050-6406 Impact factor: 4.623